Gsk Plc
Holdings as of Jun 30, 2026 · filed Aug 13, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Crispr Therapeutics Ag | $175652997 | 29.17% | — | Held |
| 2 | Wave Life Sciences Ltd | $106007465 | 17.60% | — | Held |
| 3 | Vir Biotechnology Inc | $87134221 | 14.47% | — | Held |
| 4 | Biontech Se | $82798123 | 13.75% | — | Held |
| 5 | Ideaya Biosciences Inc | $49693321 | 8.25% | — | Held |
| 6 | Cytokinetics Inc | $29001573 | 4.82% | — | Held |
| 7 | Lyell Immunopharma Inc | $21252859 | 3.53% | — | Held |
| 8 | Spero Therapeutics Inc | $20311239 | 3.37% | — | Held |
| 9 | Nkarta Inc | $8916572 | 1.48% | — | Held |
| 10 | Fulcrum Therapeutics Inc | $6535713 | 1.09% | — | Held |
| 11 | Bicycle Therapeutics Plc | $6485339 | 1.08% | — | Held |
| 12 | Cvrx Inc | $5178977 | 0.86% | — | Held |
| 13 | Regenxbio Inc | $3252043 | 0.54% | — | Held |
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.